NGS Kits Market

NGS Kits Market Overview

The NGS kits market is estimated to be worth around $1.1 billion in 2021 and is expected to grow to $11.5 billion by 2035. The field of genomic data collection and analysis has evolved significantly since the introduction of a gene sequencing method by Frederick Sanger in 1977. Advances in DNA sequencing technologies have led to significant developments in a variety of healthcare-focused research fields, such as precision medicine and diagnostics. Particularly, the impact of next generation sequencing (NGS) methods and NGS testing kit, enabling whole genome and whole exome sequencing, has been the most profound. This high throughput, parallel genome sequencing technology has greatly reduced the overall cost and time investment. In fact, compared to the Human Genome Project (~USD 3 billion), the cost of sequencing a single genome has decreased considerably (to USD 1,000), for currently available technologies. Given the ongoing innovation in NGS testing kit and NGS kits market, stakeholders further believe that, over the next decade, the aforementioned cost may further get reduced to USD 100. It is worth mentioning that this decrease in genome sequencing cost has led to an increase in the number of genomes being sequenced, across the globe. 

Despite the recent advances in the field of genomics, the nucleotide library preparation process is still marred with several challenges, including requirement of large amounts of input samples, low volume of yield and concerns related to quality of the product. In addition, the manual DNA library / RNA library preparation process is time consuming, requiring extensive manipulation and expensive reagents. Therefore, innovators in the pharmaceutical industry are constantly identifying / developing ways to improve the process of DNA library / RNA library preparation. Amidst other alternatives, the use of NGS library preparation kits has emerged as a viable option for various drug developers and academic / research institutes to overcome the existing challenges associated with conventional DNA library / RNA library preparation methods. These kits require less input material and are capable of generating precise DNA library / RNA libraries with minimum errors. Presently, more than 280 NGS library preparation kits are available in the market; these are compatible with a broad range of sequencing platforms, including Illumina®, Ion Torrent® and BGI NGS platforms. It is worth mentioning that over 3,200 patents related to NGS library preparation kits have been filed / granted in the past few years, demonstrating the continued innovation in NGS kits market. Driven by the increasing demand for gene therapies and the introduction of novel and advanced NGS techniques, the NGS library preparation kits market is anticipated to witness steady market growth during the forecast period.

Key Companies in NGS Kits Market

Examples of key companies engaged in NGS kits market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Agilent Technologies, BioDynami, Creative Biogene, New England Biolabs, PerkinElmer, Thermo Fisher Scientific, Abcam, Devyser, Diagenode, Lexogen, Roche, Tecan, Enzynomics, MGI, Takara Bio, TIANGEN Biotech, TransGen Biotech and Vazyme. This NGS kits market report includes an easily searchable excel database of all the companies providing next generation sequencing kits, worldwide.

Recent Developments in NGS Kits Market:

Several recent developments have taken place in the field of NGS kits market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

• In July 2023, Qiagen announced the expansion of its next-generation sequencing portfolio by launching QIAseq Normalizer kits in order to speed up equalizing DNA concentrations across NGS libraries. 
• In May 2023, Telesis Bio announced the first commercial shipment of its BioXp® NGS Library Prep kit for plasmid sequencing. 
• In March 2023, Qiagen entered into technology integration agreement with SOPHiA genetics. The company aims to integrate QIAseq reagent technology with SOPHiA DDMTM digital analytics platform for next-generation sequencing.

Scope of the Report

The “NGS Kits Market: Distribution by Type of Nucleotide Sequenced (DNA and RNA), Type of End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and Global Forecasts, 2022-2035” market report features an extensive study of the current market landscape, market size, market forecast and future opportunities for next generation sequencing kit during the forecast period. The market research report features an in-depth analysis of the key drivers and trends related to NGS kits market.

Amongst other elements, the market research report includes:

• A detailed assessment of the current market landscape of next generation sequencing kit, featuring information on the type of nucleotide sequenced (DNA and RNA), kit components (control total RNA / DNA, adapters, primers, enzyme mixes, buffers, RNA / DNA probes and others), quantity of sample required (less than 5 ng, 5 ng to 10 ng and more than 10 ng), turnaround time (less than 5 hours, 5 hours to 10 hours and more than 10 hours), storage temperature (deep freeze, cold and room temperature), type of sample used (purified RNA / DNA, plasma, serum, urine, cells, blood, saliva and others), kit shelf life (0.5 year and 1 year), type of sequencing (whole genome sequencing, targeted sequencing, transcriptome sequencing, RNA sequencing, ChIP sequencing, exome sequencing, bisulphite sequencing, methyl sequencing,  amplicon sequencing, de novo sequencing, resequencing and shotgun sequencing) and type of sequencing platform used (Illumina, BGI, Ion Torrent, Fluidigm and Oxford Nanopore Technologies). In addition, the chapter features analysis related to NGS library preparation kit providers based on parameters, such as year of establishment, company size, location of headquarters and leading players (in terms of number of products). 
• A competitiveness analysis of next gen sequencing kits based on various relevant parameters, namely supplier power (based on the experience of the developer) and product competitiveness (based on parameters, including type of nucleotide sequenced, kit components, quantity of sample required, turnaround time, type of sample used, kit shelf life, type of sequencing and type of sequencing platform used).
• Elaborate profiles of prominent players offering next gen sequencing kits, based in North America, Europe and Asia Pacific. Each profile features a brief overview of the company, details related to its financials (if available), product portfolio, recent developments and an informed future outlook.
• An in-depth analysis of the various patents that have been filed / granted related to next gen sequencing kits and reagents, from January 2020 to October 2021, taking into consideration parameters, such as publication year, geographical region, CPC symbols, patent focus areas, type of applicant and leading players (in terms of size of intellectual property portfolio). It also includes a patent benchmarking analysis and a detailed valuation analysis.
• A case study on the history and evolution of genome sequencing with details on first, second and third generation sequencing platforms. The chapter includes information on the NGS technologies that are available till date. Further, it presents information on the various NGS service providers (industry and non-industry players) that are engaged in providing whole genome, whole exome and targeted sequencing services.  

One of the key objectives of this market report is to provide a detailed market forecast analysis in order to estimate the existing market size and future opportunity for NGS kits market during the forecast period. We have provided an informed estimate on the likely evolution of the market over the forecast period 2021-2035. The market report features sales forecasts for the overall NGS kits market, wherein both the current and upcoming opportunity is segmented across [A] type of nucleotide sequenced (DNA and RNA), [B] type of end user (academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others) and [C] key geographies (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America and Rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

Frequently Asked Questions

Question 1: What is next generation sequencing?

Answer: Next generation sequencing refers to parallel sequencing technique which offers high throughput, scalability of operation and quick turnaround times. The technology is utilized to identify the sequence of nucleotides in targeted regions of DNA or RNA.

Question 2: How big is the NGS kits market?

Answer: The NGS kits market size is estimated to be worth $1.1 billion in 2021.

Question 3: What is the projected market growth of the NGS kits market?

Answer: The NGS kits market is expected to grow at compounded annual growth rate (CAGR) of over 18% during the forecast period.

Question 4: Who are the leading players in the NGS kits market?

Answer: Examples of key companies engaged in NGS kits market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Agilent Technologies, BioDynami, Creative Biogene, New England Biolabs, PerkinElmer, Thermo Fisher Scientific, Abcam, Devyser, Diagenode, Lexogen, Roche, Tecan, Enzynomics, MGI, Takara Bio, TIANGEN Biotech, TransGen Biotech and Vazyme.

Question 5: How many companies are currently engaged in the NGS kits market?

Answer: Close to 60 companies are currently engaged in the NGS kits market.

Question 6: How many next generation sequencing kits are presently offered by companies engaged in the industry?

Answer: More than 280 next generation sequencing kits are presently offered by companies engaged in the industry.

Question 7: Which region is the hub for companies engaged in the NGS kits market?

Answer: North America emerged as the hub for companies engaged in the NGS kits market, with over 60% of the players established in the region.